Aditxt, Inc. Excess Stock, Shares Issued
Aditxt, Inc. (ADTX) had Excess Stock, Shares Issued of 157 shares as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure
us-gaap:ExcessStockSharesIssued · last filed 2024-04-16
- 2023-09-30: Excess Stock, Shares Issued 157.00 shares.
- 2023-06-30: Excess Stock, Shares Issued 3.40K shares.
- 2023-03-31: Excess Stock, Shares Issued 1.73K shares.
- 2022-12-31: Excess Stock, Shares Issued 1.22M shares.
| Period end | Excess Stock, Shares Issued | Excess Stock, Shares Issued as first filed |
|---|---|---|
| 2023-09-30 | 157.00 shares 10-Q · filed 2023-11-14 | |
| 2023-06-30 | 3.40K shares 10-Q · filed 2023-08-14 | |
| 2023-03-31 | 1.73K shares 10-Q · filed 2023-05-15 | |
| 2022-12-31 | 1.22M shares 10-K · filed 2023-04-17 | |
| 2022-12-20 | 50.00M shares 10-Q · filed 2023-05-15 | |
| 2022-06-15 | 407.99K shares 10-K · filed 2023-04-17 | |
| 2021-12-31 | 189.84K shares 10-K · filed 2023-04-17 | 9.49M shares 10-K · filed 2022-03-31 |
| 2021-09-30 | 23.27K shares 10-Q · filed 2022-11-14 | 1.16M shares 10-Q · filed 2021-11-15 |
| 2021-08-31 | 2.29K shares 10-K · filed 2024-04-16 | |
| 2021-06-30 | 1.16M shares 10-Q · filed 2022-08-15 | |
| 2021-03-31 | 1.16M shares 10-Q · filed 2022-05-16 | |
| 2020-12-31 | 4.30M shares 10-K · filed 2022-03-31 | |
| 2020-09-30 | 3.74M shares 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |